Vertex Shares Rising on Expanded Therapy Offerings

The company develops therapies to battle cystic fibrosis and recently gained an exclusive license for technology related to battling Type 1 diabetes too. VRTX also is an earnings superstar. Its latest quarterly net product revenues grew 13.5% on a year-over-year basis, and analysts predict a 6.8% revenue jump next quarter versus the prior year.

It’s no wonder VRTX shares are up 19% this year – and they could rise more. MAPsignals data shows how Big Money investors are betting heavily on the forward picture of the stock.

Big Money Loves Vertex

Institutional volumes reveal plenty. In the last year, VRTX has enjoyed strong investor demand, which we believe to be institutional support.

Each green bar signals unusually large volumes in VRTX shares. They reflect our proprietary inflow signal, pushing the stock higher:

Plenty of health care names are under accumulation right now. But there’s a powerful fundamental story happening with Vertex.

Vertex Fundamental Analysis

Institutional support and a healthy fundamental backdrop make this company worth investigating. As you can see, VRTX has had strong sales and earnings growth:

• 3-year sales growth rate (+16.7%)
• 3-year EPS growth rate (+12.7%)

Source: FactSet

Also, EPS is estimated to ramp higher this year by +7%.

Now it makes sense why the stock has been powering to new heights. VRTX has a track record of strong financial performance.

Marrying great fundamentals with our proprietary software has found some big winning stocks over the long term.

Vertex has been a top-rated stock at MAPsignals for a while. That means the stock has unusual buy pressure and growing fundamentals. We have a ranking process that showcases stocks like this on a weekly basis.

It’s made the rare Top 20 report multiple times in the last three years. The blue bars below show when VRTX was a top pick…generating value with time:

Tracking unusual volumes reveals the power of money flows.

This is a trait that most outlier stocks exhibit…the best of the best. Big Money demand drives stocks upward.

Vertex Price Prediction

The VRTX rally isn’t new at all. Big Money buying in the shares is signaling to take notice. Given the historical gains in share price and strong fundamentals, this stock could be worth a spot in a diversified portfolio.

Disclosure: the author holds no position in VRTX at the time of publication.

If you are a Registered Investment Advisor (RIA) or are a serious investor, take your investing to the next level, learn more about the MAPsignals process here.